DSIJ Mindshare

The Indian Biotech Leader Expands its Operations in the U.S. Strategically Through the Launch of a New Biosimilar

Over the past year, Biocon delivered a return of 15.51 per cent, while its three-year return stood at -9.75 per cent.

DSIJ Intelligence-2 0 144 Article rating: 5.0

Over the past year, Biocon delivered a return of 15.51 per cent, while its three-year return stood at -9.75 per cent.

Pharma Stocks Under Pressure: Shares Drop Nearly 4 per cent Despite Diabetes and Obesity Drug Launch in UK

With GLP-1 therapies expected to be a significant revenue driver in the future, Biocon aims to strengthen its footprint in this segment.

DSIJ Intelligence 0 151 Article rating: 4.3

With GLP-1 therapies expected to be a significant revenue driver in the future, Biocon aims to strengthen its footprint in this segment.

This Pharma Stock Declines 4.86 per cent; Board Approves Rs 570 Crore Fundraise, Know the Stock Outlook Here

The Board of Directors approved the issuance of commercial papers worth Rs 570 crore on a private placement basis

DSIJ Intelligence 0 297 Article rating: 3.3

The Board of Directors approved the issuance of commercial papers worth Rs 570 crore on a private placement basis

Overnight Digest: Stocks to keep an eye on June 24

Auto stocks took the lead with BSE Auto Index adding up to 4 per cent. The top three auto stocks lifting the index were Maruti Suzuki, Here MotoCorp and Eicher Motors zooming up to 6.6 per cent.

DSIJ Intelligence 0 1623 Article rating: 3.2

Following the Asian market, the domestic indices opened on a positive note on Thursday. The markets cut some gains in the afternoon session but managed to remain in green.

Overnight Digest: Stocks likely to be in focus on June 9

Realty index gained up to 1.88 per cent as RBI permitted rural cooperative banks to extend finance for a residential housing project to further augment credit flows to the housing sector.

DSIJ Intelligence 0 1163 Article rating: 3.3

On Wednesday, the benchmark indices remained under pressure post the repo rate hike. RBI hiked the key policy repo rate by 50 bps to 4.90 per cent whereas the markets were relieved, as there was no CRR hike. The repo rate hike by RBI is likely to impact the home loan borrowers, both the existing as well as the new ones. While the hike is positive for the banks and the NBFCs, it is likely to be a burden for the borrowers. 

RSS
123
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR